KOREAN
Company Business R & D Investors

Global Stem Cell Company

Investors

Notice IR
Disclosure Information Stock Information IR Resource Center IR Letter & FAQ
PR
Press Release PR Resource Center

IR Letter & FAQ

InvestorsIRIR Letter & FAQ

ir@kangstem.com, 02-888-1590

목록으로

[매일경제] HIV·루프스·아토피…난치성 질환 게 섰거라 (19.01.13)

2019.01.14
[매일경제] HIV·루프스·아토피…난치성 질환 게 섰거라 (19.01.13)

[매일경제] HIV·루프스·아토피…난치성 질환 게 섰거라


http://news.mk.co.kr/newsRead.php?year=2019&no=25817

목록으로

  [한국경제] 크론병 치료제 임상 지난해 두 배 늘어난 까닭은 (19.01.14)   [뉴스1/JP모건] "강스템바이오텍 아토피 신약 연내 유럽임상 신청" (19.01.09)
About Us Stock Information Careers Contact Us
Global R&D Center Stem Cell GMP Center Pipeline
TOP
Kangstem Biotech Co., Ltd.
9th Floor, Hongwoo Bldg., 522 Teheran-ro, Gangnam-gu, Seoul

COPYRIGHT © 2015 KANGSTEM BIOTECH ALL RIGHTS RESERVED.
Go
board : irletter : view : : /board/irletter/view